Hospital Regional Universitario de Málaga-ko ikertzaileekin lankidetzan egindako argitalpenak (10)

2020

  1. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  2. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

2019

  1. Polymorphisms in CEP68 gene associated with risk of immediate selective reactions to non-steroidal anti-inflammatory drugs

    Pharmacogenomics Journal, Vol. 19, Núm. 2, pp. 191-199

2017

  1. Rationale and design of the multiethnic Pharmacogenomics in Childhood Asthma consortium

    Pharmacogenomics, Vol. 18, Núm. 10, pp. 931-943

2016

  1. Copy number variation in ALOX5 and PTGER1 is associated with NSAIDs-induced urticaria and/or angioedema

    Pharmacogenetics and Genomics, Vol. 26, Núm. 6, pp. 280-287

  2. Genetic variants of thymic stromal lymphopoietin in nonsteroidal anti-inflammatory drug-induced urticaria/ angioedema

    International Archives of Allergy and Immunology, Vol. 169, Núm. 4, pp. 249-255

  3. Genome-wide association study in Spanish identifies ADAM metallopeptidase with thrombospondin type 1 motif, 9 (ADAMTS9), as a novel asthma susceptibility gene

    Journal of Allergy and Clinical Immunology, Vol. 137, Núm. 3, pp. 964-966

2015

  1. Fine mapping of the myosin light chain kinase (MYLK) gene replicates the association with asthma in populations of Spanish descent

    Journal of Allergy and Clinical Immunology, Vol. 136, Núm. 4, pp. 1116-1118.e9

2014

  1. HLA-DRB1∗15:01 allele protects from asthma susceptibility

    Journal of Allergy and Clinical Immunology, Vol. 134, Núm. 5, pp. 1201-1203

2012

  1. Genetic variants of the arachidonic acid pathway in non-steroidal anti-inflammatory drug-induced acute urticaria

    Clinical and Experimental Allergy, Vol. 42, Núm. 12, pp. 1772-1781